AGP acquires portfolio of products from American pharma firm Viatris
AGP claims newly acquired products will add Rs20b to annual revenues
IPO proceeds in 2018 plunged by 49% to Rs4.8 billion
AGP Pharmaceutical, one of the largest companies in the country’s pharmaceutical sector via its offer for sale (OFS) collected 65% of total raised capital during 2018
AGP Ltd raises Rs2.8 bn in IPO
KARACHI: AGP Limited, a part of OBS Group, the 8th largest Pharmaceutical Group in Pakistan, successfully raised Rs2.8 billion from foreign, local...
Sanofi-Aventis Pakistan’s sole shareholder to transfer its shareholding to subsidiary Zentiva NV
LAHORE: Sanofi-Aventis Pakistan (Ltd) on Friday announced that the sole shareholder of SECIPE, i.e. Sanofi S.A. has made a decision to disincorporate...
Pharma has potential to surpass textile industry in Pakistan: Chairman AGP
KARACHI:Â The pharmaceutical industry in Pakistan has the potential to increase its exports to such an extent that it can become the biggest...
UK report claims Pakistan’s Covid-19 medicine enough for national demand
Pakistan, along with India, is the only one among developing countries to have effectively stored enough of Remdesivir to meet their national...
Govt decision to increase medicine prices augurs well for domestic drugmakers: Fitch Solutions
Revenue generating opportunities for local pharmaceutical companies in Pakistan will improve following the decision by the government to increase the prices of medicines, said Fitch Solutions
Pharma industry protests govt’s refusal to increase drug prices
LAHORE: The Ministry of National Health Service Regulations and Coordination on Monday announced that there will be no immediate increase in drug...
The magic pill for the pharma sector
Will the deregulation in drug pricing policy prove to be the long awaited cure for the pharmaceutical industry?
Pharmaceuticals may turn to Chinese raw material as tensions with India soar
Pakistan has formulated a strategy to deal with any crisis arising out of an embargo on the import of raw material supplied...
PPMA vs DRAP: Pharma crisis continuesÂ
Unavailability of medicines could inevitably trigger national health emergency
Fate of Pfizer’s consumer business in spotlight after Merck sells its unit
NEW YORK: With the sale of Merck's consumer healthcare business to Procter & Gamble, the spotlight now shifts to the fate of Pfizer's consumer...
GSK set to capitalise as Reckitt Benckiser pulls out of Pfizer deal
NEW YORK:Â British consumer goods group Reckitt Benckiser has pulled out of discussions with Pfizer over buying its consumer healthcare business, strengthening the...
Medicinal imports rise 3.54pc to $929m
ISLAMABAD:Â Pakistan has imported medicinal products worth $929.355 million during the first ten months of the current fiscal year, showing a growth of...
Do cures harm the drug business?
OTTAWA: "Is curing patients a sustainable business model?" That provocative question was posed on page 38 of a Goldman Sachs research report...